Metadata
Title
Rosado-Olivieri Lab
Category
general
UUID
533f8acc9dc6406793f0c264d6b06bdf
Source URL
https://dental.nyu.edu/faculty/molecular-pathobiology/rosado-olivieri-lab.html?c...
Parent URL
https://engineering.nyu.edu/academics/departments/biomedical-engineering/labs-an...
Crawl Time
2026-03-23T11:42:53+00:00
Rendered Raw Markdown

Rosado-Olivieri Lab

Source: https://dental.nyu.edu/faculty/molecular-pathobiology/rosado-olivieri-lab.html?challenge=d06e90d7-4d8f-4b88-9d8c-10b73beb60f1 Parent: https://engineering.nyu.edu/academics/departments/biomedical-engineering/labs-and-groups

Laboratory of Human Organogenesis

Rosado-Olivieri Lab

Edwin Rosado-Olivieri, PhD

Assistant Professor\ Division of Biomaterials and Regenerative Biology\ Department of Molecular Pathobiology\ NYU College of Dentistry

Biography

Dr. Rosado-Olivieri is a stem cell and developmental biologist whose work focuses on the development of stem cell-based models, computational, and genetic approaches to uncover fundamental aspects of human embryology and disease. He obtained his doctoral degree in Stem Cell and Regenerative Biology from Harvard Medical School, under the mentoring of Dr. Douglas Melton, after completing his bachelor’s degree in Cell and Molecular Biology from the University of Puerto Rico. During his graduate training, he developed methods to generate virtually unlimited quantities of functional insulin-producing beta cells from human pluripotent stem cells in vitro, an approach that is currently being tested in clinical trials as a potential cell replacement therapy for diabetic patients. As a postdoctoral scholar, he joined the laboratory of Dr. Ali Brivanlou at the Rockefeller University, where he developed a platform to generate human mini-lungs at a high-throughput scale. In collaboration with Nobel Laureate Dr. Charles Rice, they used this platform to uncover critical insights into the pathogenesis of COVID-19 and other respiratory viruses and identify antiviral therapeutics at scale. As a founding member and former Vice President at RumiViro, he spearheaded pioneering scientific initiatives dedicated to uncovering and advancing groundbreaking therapeutics targeting respiratory viruses and chronic kidney diseases. Among his awards, he is the recipient of the Merit Award from the International Society for Stem Cell Research in 2019, Blavatnik Biomedical Accelerator Award in 2019, Harvard Distinction in Teaching Award in 2016, and UPR Distinction in Research Award in 2015.

Contact

Molecular Pathobiology\ New York University College of Dentistry\ 345 East 24th Street, Room 807\ New York, NY 10010\ Office: 212 998-9637 (ext. 89637)\ Email: er3400@nyu.edu

###### Research

###### Publications

###### Research Team

###### News

###### Vacancies